Improving the treatment of Epstein-Barr virus infectious mononucleosis in children

Journal Title: Актуальна інфектологія - Year 2018, Vol 6, Issue 2

Abstract

Background. In Ukraine, as in the whole world, there is a tendency to increase in the number of diffuse liver diseases. Increased percentage of patients with liver disease among adults is mostly determined by the damages to hepatobiliary system in childhood. The purpose of the study was to evaluate the effectiveness of ursodeoxycholic acid (UDCA) in the therapy of liver damages due to Epstein-Barr virus (EBV). Materials and methods. Research design: prospective, open-label, controlled. Sixty children with EBV infectious mononucleosis (IM) aged 1 to 18 years old were screened. All patients were observed, examined during the acute period of the disease, and divided into 2 groups. The children of the main group (n = 35) received standard therapy for EBV IM in combination with UDCA, patients of the control group (n = 25) received standard treatment alone. Results. Received data showed that therapy improved by means of UDCA in EBV IM and liver damage promotes a faster regression of the main symptoms of infection, such as fever, appetite loss and jaundice, already on day 7 from the beginning of treatment and a more rapid norma­lization of indicators of the functional state of the liver (alanine aminotransferase, bilirubin, alkaline phosphatase, gamma glutamyltransferase, lactate dehydrogenase). The drug was well tolerated, no adverse reactions were observed. Conclusions. The inclusion of UDCA in the treatment scheme can improve the effectiveness of advanced therapy compared with standard one, promotes a more rapid regression of infection symptoms and a more rapid norma­lization of indicators of the functional state of the liver.

Authors and Affiliations

S. O. Кramarov, V. O. Shadrin, V. V. Yevtushenko, I. V. Shpak, L. A. Bolshakova, Т. M. Kaminskaya

Keywords

Related Articles

The aromatherapy for the treatment and prevention of acute respiratory infections in children

The article covers the history of aromatherapy, the mechanisms of essential oils influence on the human body, and the specific features of their therapeutic effect. The main principles of the use of essential oils, dosag...

Clinical Forms of Chronic Epstein — Barr Virus Infection: Questions of Modern Diagnosis and Treatment

The article discussed in detail the questions of clinical picture, diagnosis and treatment of Epstein — Barr virus infection. The basic methods of modern laboratory diagnosis of this disease are given, and the list of ex...

Aspects of treatment of lower respiratory tract infections in terms of clinical guidelines of different countries (bronchiolitis, bronchitis, community-acquired pneumonia)

According to the international protocols, the treatment of lower respiratory tract infections has its own characteristics in different countries. In general, only oxygen therapy and proper hydration have sufficient evide...

Achievements and problems of immunoprophylaxis of infectious diseases in children at the present stage. Problems in the immunization of the population

The article presents data on the state of immunization against major vaccine-controlled infections in international and regional subnational aspects. Some factors of the worsening of the epidemiological situation in Ukra...

Poliomyelitis in Children

The article deals with the problem of poliomyelitis in children. The history of this disease and the current state of morbidity in Ukraine are considered. The features of the clinical pattern in children are described. D...

Download PDF file
  • EP ID EP289583
  • DOI 10.22141/2312-413x.6.2.2018.131095
  • Views 81
  • Downloads 0

How To Cite

S. O. Кramarov, V. O. Shadrin, V. V. Yevtushenko, I. V. Shpak, L. A. Bolshakova, Т. M. Kaminskaya (2018). Improving the treatment of Epstein-Barr virus infectious mononucleosis in children. Актуальна інфектологія, 6(2), 87-92. https://europub.co.uk./articles/-A-289583